Riken Vitamin Co., Ltd. (4526.T) JPX

3,005.00

+6(+0.20%)

Updated at September 09 11:30AM

Currency In JPY

Valuation

Market Cap73.24B
Enterprise Value60.86B
P/E Ratio10.14
PEG Ratio-1.86
Price/Sales Ratio0.94
Price/Book Ratio1.13
Enterprise/Revenue0.84
Enterprise/EBITDA5.09

Fiscal Year

Fiscal YearMarch 31, 2025
Most Recent QuarterJune 30, 2025

Profitability

Profit Margin0.09
Operating Margin0.09

Management Effectiveness

Return On Assets0.08
Return On Equity0.11

Income Statement

Revenue95.58B
Revenue/Share3,190.77
Gross Profit31.27B
EBITDA16.04B
Net Income9.39B
Diluted EPS310.06

Balance Sheet

Total Cash20.05B
Total Cash/Share671.75
Total Debt10.13B
Total Debt/Equity0.13
Current Ratio3.18
Book Value Per Share2,649.42

Price History

52-Week Change15.44
52-Week High3,025
52-Week Low2,204
Moving Average 50 Days2,843.28
Moving Average 200 Days2,555.63

Statistics

Average Volume54,338
Shares Outstanding29.79M
% Held by InstitutionsN/A

Dividend And Splits

Trailing Annual Dividend Rate94
Trailing Annual Dividend Yield3.13
Payout Ratio0
Last Split Factor2:1
Last Split DateMarch 30, 2020